Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 192
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00176813 | Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer | ||
| NCT04766190 | DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer | ||
| NCT06420167 | DapagliFLOzin in Renal AL Amyloidosis (FLORAL) | ||
| NCT03091257 | A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma | ||
| NCT05903092 | MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer | ||
| NCT01116232 | Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation | ||
| NCT04037462 | Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy | ||
| NCT00011973 | Chemotherapy in Treating Patients With Advanced Kidney Cancer | ||
| NCT00068653 | Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer | ||
| NCT01888198 | Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment | ||
| NCT04479267 | Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma | ||
| NCT06501040 | Increasing Knowledge and Interest in Cancer Clinical Trials | ||
| NCT00972023 | DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer | ||
| NCT00897741 | Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer | ||
| NCT01812668 | Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer | ||
| NCT00301808 | Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer | ||
| NCT03147885 | Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma | ||
| NCT00897910 | Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma | ||
| NCT00888654 | Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy | ||
| NCT03684005 | MyPatientPal: An App to Help Patients Manage Their Cancer Care | ||
| NCT01813370 | A Registry for Patients Treated on the Clinical Trial TAX 3503 | ||
| NCT01205646 | PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer | ||
| NCT00503841 | Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer | ||
| NCT05738005 | Dietary Reporting In The Amyloidoses | ||
| NCT03328091 | Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen) | ||
| NCT03183050 | MEND 2: Making Treatment Decisions Using Genomic Testing | ||
| NCT00002552 | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma | ||
| NCT00005027 | Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer | ||
| NCT05028374 | COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies | ||
| NCT00438204 | Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | ||
| NCT05222438 | Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant | ||
| NCT00004022 | Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma | ||
| NCT00003220 | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | ||
| NCT03719677 | Reducing Metabolic Syndrome Among Breast Cancer Survivors | ||
| NCT00288028 | Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant | ||
| NCT02178436 | Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer | ||
| NCT06537687 | Relational Agents in Cervical Cancer Education (RACE) | ||
| NCT07436078 | Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors | ||
| NCT00002907 | Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma | ||
| NCT01051570 | Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel | ||
| NCT00935090 | 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer | ||
| NCT00227721 | Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer | ||
| NCT02906241 | PACCT: Partnering Around Cancer Clinical Trials | ||
| NCT00238329 | PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma | ||
| NCT00002585 | Pyrazoloacridine in Treating Women With Metastatic Breast Cancer | ||
| NCT00056004 | Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia | ||
| NCT00960427 | Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | ||
| NCT01609816 | Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma | ||
| NCT07118202 | TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma | ||
| NCT00078923 | Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate |
